Percutaneous transluminal coronary angioplasty and stent placement in pregnancy.
BACKGROUND
Myocardial infarction (MI) is uncommon during pregnancy. As the average maternal age increases and assisted reproductive technology allows for very advanced maternal ages, so too may the incidence of MI during pregnancy. Percutaneous transluminal coronary angioplasty (PTCA) with stent placement is an attractive option for treatment of MI in pregnancy when revascularization is required.


METHODS
We present a gravida with an ST elevation MI during the third trimester, who was treated with emergent PTCA, stent placement, and platelet inhibitors, and we discuss the patient's subsequent obstetric and anesthetic management.


CONCLUSIONS
Percutaneous transluminal coronary angioplasty with stent placement may be used during the third trimester with successful outcome.
Dwyer
Bonnie K
BK
Department of Obstetrics, Stanford University, Stanford, California 94305, USA. dwyerb@stanford.edu
Taylor
Larisa
L
Fuller
Andrea
A
Brummel
Catherine
C
Lyell
Deirdre J
DJ
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008423:Maternal Age; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy*; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D015607:Stents
D010975:Platelet Aggregation Inhibitors